Analysing Competitiveness of the Hungarian Agro-Food Chains

Based on the Policy Analysis Matrix (PAM) approach this paper provides an assessment of the competitive position of the Hungarian agro-food industry in view of EU integration. The situation in the food processing sector is assessed with the use of actual cost data from representative Hungarian companies. The paper presents an assessment of the current situation prior to EU integration as well as a future outlook under various scenarios with regard to the expected policy environment and the rate of technological change. The actual measurement of competitiveness in this study focuses mainly on Private Resource Cost (PRC) which indicates competitiveness under real market conditions and Domestic Resource Cost (DRC) which gives an assessment on the social or economic efficiency of an activity, i.e. whether domestic resources are really used efficiently in current production. In the food processing sector 21 different food products have been investigated which fall into four industries: meat, poultry, dairy, and fruits and vegetables. Under current conditions only some products are competitive in private terms. The situation would improve after EU integration especially for poultry, fruits and vegetables, because agricultural policy conditions are more favourable under the CAP. If additional FDI(Foreign Direct Investments) would flow into the country after EU membership, this would boost profitability. As far as DRC values are concerned, it must be stated that only some of the production activities are clearly efficient. Dairy, fruits and vegetables, and roast goose production show relatively weak social competitiveness, while other poultry and fruit and vegetables products are more favourable from the economic point of view. As EU policies provide on average higher protection levels, the competitiveness of Hungarian food processing on world markets would deteriorate for most products after EU accession. However, these effects can be offset by additional technological change due to FDI inflows or otherwise induced technological progress.competitiveness, strategy, accession, technology development, investment, Agribusiness,

The impact of fusion-born alpha particles on runaway electron dynamics in ITER disruptions

In the event of a tokamak disruption in a D-T plasma, fusion-born alpha particles take several milliseconds longer to thermalise than the background. As the damping rates drop drastically following the several orders of magnitudes drop of temperature, Toroidal Alfven Eigenmodes (TAEs) can be driven by alpha particles in the collapsing plasma before the onset of the current quench. We employ kinetic simulations of the alpha particle distribution and show that the TAEs can reach sufficiently strong saturation amplitudes to cause significant core runaway electron transport in unmitigated ITER disruptions. As the eigenmodes do not extend to the plasma edge, this effect leads to an increase of the runaway electron plateau current. Mitigation via massive material injection however changes the Alfven frequency and can lead to mode suppression. A combination of the TAE-caused core runaway electron transport with other perturbation sources could lead to a drop of runaway current in unmitigated disruptions

Plasmonic nanoresonator distributions for uniform energy deposition in active targets

Active targets implanted with core-shell-composition (CS) and nanorod-shaped (NR) plasmonic nanoresonators and doped with dyes were designed to ensure uniform energy deposition during illumination by two-counter propagating short laser pulses. The near-field enhancement, optical responses, and cross-sections were mapped above the concentration-Epump parameter-plane to inspect two different regions (I and II) with the potential to improve light-matter interaction phenomena. The distribution of steady-state absorption, as well as of the power-loss and power-loss density integrated until the complete overlap of the two short pulses was determined. The uniform distribution was adjusted to constrain standard deviations of the integrated power-loss distributions in the order of ∼10%. Dye doping of target-I/II implanted with uniform CS (NR) nanoresonator distributions results in larger absorption with increased standard deviation, larger power-loss, and power-loss density with decreased (decreased / increased) standard deviation. The adjustment allows larger absorption in CS-II and larger power-loss and power-loss density in CS-implanted targets, smaller standard deviation in targets-I for absorption, and in all targets for power-loss and its density. Larger dye concentration makes it possible to achieve larger absorption (except in adjusted NR-II), larger power-loss and power-loss density in all CS and in adjusted NR distributions, with decreased standard deviation in CS-implanted targets for all quantities and in NR-implanted targets for absorption. CS implantation results in larger absorption with a larger standard deviation, moreover allows larger power-loss in adjusted distributions and smaller standard deviation in power-loss quantities for larger concentration in both distributions and the same standard deviation for smaller concentration in adjusted distribution. Based on these results, adjusted CS distributions in targets doped with a dye of higher concentration are proposed.publishedVersio

Association of symptoms of insomnia and sleep parameters among kidney transplant recipients

Objective: Insomnia complaints are frequent among kidney transplant (kTx) recipients and are associated with fatigue, depression, lower quality of life and increased morbidity. However, it is not known if subjective insomnia symptoms are associated with objective parameters of sleep architecture. Thus, we analyze the association between sleep macrostructure and EEG activity versus insomnia symptoms among kTx recipients. Methods: Participants (n1 = 100) were selected from prevalent adult transplant recipients (n0 = 1214) followed at a single institution. Insomnia symptoms were assessed by the Athens Insomnia Scale (AIS) and standard overnight polysomnography was performed. In a subgroup of patients (n2 = 56) sleep microstructure was also analyzed with power spectral analysis. Results: In univariable analysis AIS score was not associated with sleep macrostructure parameters (sleep latency, total sleep time, slow wave sleep, wake after sleep onset), nor with NREM and REM beta or delta activity in sleep microstructure. In multivariable analysis after controlling for covariables AIS score was independently associated with the proportion of slow wave sleep (β = 0.263; CI: 0.026–0.500) and REM beta activity (β = 0.323; CI = 0.041–0.606) (p < 0.05 for both associations). Conclusions: Among kTx recipients the severity of insomnia symptoms is independently associated with higher proportion of slow wave sleep and increased beta activity during REM sleep but not with other parameters sleep architecture. The results suggest a potential compensatory sleep protective mechanism and a sign of REM sleep instability associated with insomnia symptoms among this population

HAT-P-9b: A Low Density Planet Transiting a Moderately Faint F star

We report the discovery of a planet transiting a moderately faint (V=12.3 mag) late F star, with an orbital period of 3.92289 +/- 0.00004 days. From the transit light curve and radial velocity measurements we determine that the radius of the planet is R_p = 1.40 +/- 0.06 R_Jup and that the mass is M_p = 0.78 +/- 0.09 M_Jup. The density of the new planet, rho = 0.35 +/- 0.06 g cm^{-3}, fits to the low-density tail of the currently known transiting planets. We find that the center of transit is at T_c = 2454417.9077 +/- 0.0003 (HJD), and the total transit duration is 0.143 +/- 0.004 days. The host star has M_s = 1.28 +/- 0.13 M_Sun and R_s = 1.32 +/- 0.07 R_Sun.Comment: Submitted to ApJ; V2: Replaced with accepted versio

Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease

AIM To assess the prevalence and stability of different antiphospholipid antibodies (APLAs) and their association with disease phenotype and progression in inflammatory bowel diseases (IBD) patients. METHODS About 458 consecutive patients [Crohn's disease (CD): 271 and ulcerative colitis (UC): 187] were enrolled into a follow-up cohort study in a tertiary IBD referral center in Hungary. Detailed clinical phenotypes were determined at enrollment by reviewing the patients' medical charts. Disease activity, medical treatment and data about evolvement of complications or surgical interventions were determined prospectively during the follow-up. Disease course (development f complicated disease phenotype and need for surgery), occurrence of thrombotic events, actual state of disease activity according to clinical, laboratory and endoscopic scores and accurate treatment regime were recorded during the follow-up, (median, 57.4 and 61.6 mo for CD and UC). Sera of IBD patients and 103 healthy controls (HC) were tested on individual anti-β2-Glycoprotein-I (anti-β2-GPI IgA/M/G), anti-cardiolipin (ACA IgA/M/G) and anti-phosphatidylserine/prothrombin (anti-PS/PT IgA/M/G) antibodies and also anti-Saccharomyces cerevisiae antibodies (ASCA IgA/G) by enzyme-linked immunosorbent assay (ELISA). In a subgroup of CD (n = 198) and UC patients (n = 103), obtaining consecutive samples over various arbitrary time-points during the disease course, we evaluated the intraindividual stability of the APLA status. Additionally, we provide an overview of studies, performed so far, in which significance of APLAs in IBD were assessed. RESULTS Patients with CD had significantly higher prevalence of both ACA (23.4%) and anti-PS/PT (20.4%) antibodies than UC (4.8%, P < 0.0001 and 10.2%, P = 0.004) and HC (2.9%, P < 0.0001 and 15.5%, P = NS). No difference was found for the prevalence of anti-β2-GPI between different groups (7.2%-9.7%). In CD, no association was found between APLA and ASCA status of the patients. Occurrence of anti-β2-GPI, ACA and anti-PS/PT was not different between the group of patients with active vs inactive disease state according to appropriate clinical, laboratory and endoscopic scores in CD as well as in UC patients. All subtypes of anti-β2-GPI and ACA IgM status were found to be very stable over time, in contrast ACA IgG and even more ACA IgA status showed significant intraindividual changes. Changes in antibody status were more remarkable in CD than UC (ACA IgA: 49.9% vs 23.3% and ACA IgG: 21.2% vs 5.8%). Interestingly, 59.1% and 30.1% of CD patients who received anti-TNF therapy showed significant negative to positive changes in ACA IgA and IgG antibody status respectively. APLA status was not associated with the clinical phenotype at diagnosis or during follow-up, medical therapy, or thrombotic events and it was not associated with the probability of developing complicated disease phenotype or surgery in a Kaplan-Meier analysis. CONCLUSION The present study demonstrated enhanced formation of APLAs in CD patients. However, presence of different APLAs were not associated with the clinical phenotype or disease course

HATS-18 b: An Extreme Short--Period Massive Transiting Planet Spinning Up Its Star

We report the discovery by the HATSouth network of HATS-18 b: a 1.980 +/- 0.077 Mj, 1.337 +0.102 -0.049 Rj planet in a 0.8378 day orbit, around a solar analog star (mass 1.037 +/- 0.047 Msun, and radius 1.020 +0.057 -0.031 Rsun) with V=14.067 +/- 0.040 mag. The high planet mass, combined with its short orbital period, implies strong tidal coupling between the planetary orbit and the star. In fact, given its inferred age, HATS-18 shows evidence of significant tidal spin up, which together with WASP-19 (a very similar system) allows us to constrain the tidal quality factor for Sun-like stars to be in the range 6.5 <= lg(Q*/k_2) <= 7 even after allowing for extremely pessimistic model uncertainties. In addition, the HATS-18 system is among the best systems (and often the best system) for testing a multitude of star--planet interactions, be they gravitational, magnetic or radiative, as well as planet formation and migration theories.Comment: Submitted. 12 pages, 9 figures, 5 table

Rediscovery of the Anti-Pancreatic Antibodies and Evaluation of their Prognostic Value in a Prospective Clinical Cohort of Crohn's Patients: The Importance of Specific Target Antigens [GP2 and CUZD1].

BACKGROUNDS Glycoprotein 2[GP2] and CUB zona pellucida-like domain 1[CUZD1] belong to protein families involved in gut innate immunity processes and have recently been identified as specific targets of anti-pancreatic autoantibodies [PAbs] in Crohn's disease[CD]. We aimed to determine the prognostic potential of novel target-specific PAbs regarding long-term disease course of an adult CD patient cohort. METHODS Sera of 458 consecutive well-characterised IBD patients from a single referral IBD centre were tested by enzyme-linked immunosorbent assay [ELISA] with isoform 4 of recombinant GP2 [anti-MZGP2 and anti-GP2 IgA/IgG] and indirect immunofluorescence test [IIFT] system with GP2 and CUZD1 expressing transfected HEK 293 cells [anti-rPAg2 and rPAg1 IgA/IgG]. Clinical data were available on complicated disease or surgical interventions as well as disease activity and medical treatment during the prospective follow-up [median, 108 months]. RESULTS Totals of 12.4% and 20.8% of CD patients were positive for IgA/IgG type of anti-GP2 and anti-CUZD1, respectively, with a significant difference compared with UC [p < 0.01]. Antibody status was stable over time. Agreement among three different anti-GP2 assays was good. Positivity for PAbs, mainly IgA subtypes, predicted a faster progression towards complicated disease course. In Kaplan-Meier analysis, time to surgery or development of perianal disease was associated with anti-GP2 IgA [pLogRank < 0.01] or anti-CUZD1 IgA [pLogRank < 0.001] positivity, respectively. Anti-CUZD1 IgA remained an independent predictor in the multivariate Cox-regression model (hazard ratio [HR]: 3.43, 95% confidence interval [CI]: 1.68-7.02, p < 0.001). CONCLUSIONS The present study has shown that specific PAbs [especially IgA subtype] predict complicated disease course including the development of perianal disease in CD

Presence of Anti-Microbial Antibodies in Liver Cirrhosis – A Tell-Tale Sign of Compromised Immunity?

Bacterial translocation plays important role in the complications of liver cirrhosis. Antibody formation against various microbial antigens is common in Crohn's disease and considered to be caused by sustained exposure to gut microflora constituents. We hypothesized that anti-microbial antibodies are present in patients with liver cirrhosis and may be associated with the development of bacterial infections.<0.001, OR:2.02) by Cox-regression analysis.The present study suggests that systemic reactivity to microbial components reflects compromised mucosal immunity in patients with liver cirrhosis, further supporting the possible role of bacterial translocation in the formation of anti-microbial antibodies